Pfizer withdraws all lots of Oxbryta (voxelotor) for the treatment of sickle cell disease
Pfizer Inc. announced that it is voluntarily withdrawing all lots of Oxbryta voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where… read more.